Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
60S ribosomal protein L21 pseudogene refers to one of the many non-functional copies (“pseudogenes”) related to the RPL21 gene, which encodes a structural component of the eukaryotic 60S ribosomal large subunit involved in protein synthesis[1][2][5]. Pseudogenes like ENSG00000217776 do not produce active proteins and are not generally implicated as therapeutic targets, markers, or direct disease contributors[5][7]. The protein-coding version, RPL21, is involved in ribosome function and has clinical relevance in hair follicle biology and rare hereditary disorders, but the pseudogene does not share those functions[1][3][7]. Summary: ENSG00000217776 is a pseudogene, not a therapeutic or biological target. For actionable or functional relevance, search for the protein-coding RPL21 gene, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S ribosomal protein L21 pseudogene.